Hendrix Genetics and Paine Schwartz Partners completed Paine Schwartz Food Chain Fund V’s strategic investment in the company. With the transaction complete, Hendrix Genetics is poised to continue investing across its breeding programs, enhancing its technology and data capabilities, growing its global customer base and expanding into new markets.

“With the completion of this investment, we are beginning Hendrix Genetics’ next phase of growth and success,” said Thijs Hendrix, co-founder and chairman of the Supervisory Board of Hendrix Genetics. “We are pleased to officially welcome the teams from Paine Schwartz, Mitsui & Co., Rabo Investments and our other new partners and look forward to benefiting from their expertise and support. Together, we will build on our strong foundation and provide our genetics and breeding solutions to customers across the global food chain.”

Jolanda van Haarlem, chief executive officer of Hendrix Genetics, said that “this is an exciting and important time for Hendrix Genetics. With our new investors now on board, we are well prepared to accelerate our evolution, enhance our industry-leading capabilities and become an even better partner to our valued customers. We intend to move full speed ahead as we work to meet the global food challenge head-on with technology and innovative solutions for the animal protein sector delivered to more markets around the globe.”

Kevin Schwartz, chief executive officer of Paine Schwartz, said that “with its best-in-class data and technology-enabled breeding programs, we believe that Hendrix Genetics is poised to capture significant opportunities ahead. Hendrix Genetics directly aligns with our focus on investing in companies across the food chain with sustainability at their core. We look forward to collaborating with our co-investors and supporting the Hendrix Genetics team as they grow the business and continue to set the standard for sustainable animal breeding.”

Paine Schwartz and its affiliated co-investors, including Mitsui & Co. and Rabo Investments (the investment arm of Rabobank Group), now hold 50% ownership in the company with Hendrix Genetics’ co-founders, Thijs Hendrix and Antoon van den Berg, holding the remaining 50% ownership position in the company.